§ 14-44.1. Providing or advertising abortion-inducing drugs to pregnant woman.

304 words·~1 min read·/nc/chapter-14/14-44-1

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)Offense. - All of the following are unlawful:

(1)For any individual within the State, including a physician, an employee or contractor of a physician's office or clinic, or other abortion provider, or organization within the State, including a physician's office or clinic or other abortion provider, to mail, provide, or supply an abortion-inducing drug directly to a pregnant woman in violation of G.S. 90-21.83A(b)(2)a. Lack of knowledge or intent that the abortion-inducing drug will be administered outside the physical presence of a physician shall not be a defense to a violation of this subdivision.

(2)For any manufacturer or supplier of an abortion-inducing drug to ship or cause to be shipped any abortion-inducing drug directly to a pregnant woman in violation of G.S. 90-21.83A(b)(2)a. Lack of knowledge or intent that the abortion-inducing drug will be administered outside the physical presence of a physician shall not be a defense to a violation of this subdivision.

(3)For any individual or organization to purchase or otherwise procure an advertisement, host or maintain a website, or provide an internet service purposefully directed to a pregnant woman who is a resident of this State when the individual or organization knows that the purpose of the advertisement, website, or internet service is solely to promote the sale of an abortion-inducing drug to be administered to a woman in violation of G.S. 90-21.83A(b)(2)a.

(b)Punishment. - An individual or organization who violates this section commits an infraction as defined in G.S. 14-3.1 and is subject to a fine of five thousand dollars ($5,000) per violation.

(c)Definitions. - The following definitions apply in this section:

(1)Abortion-inducing drug. - As defined in G.S. 90-21.81(1a).

(2)Organization. - As defined in G.S. 15A-773(c). (2023-14, s. 1.3; 2025-25, s. 29(5).)